Charles M. Rudin, MD, PhD

Chief, Thoracic Oncology Service
Pictured: Charles Rudin

I am a board-certified medical oncologist specializing in the care of patients with lung cancer.  In addition to serving as Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center, I co-chair the Eastern Cooperative Oncology Group Thoracic Committee, and am a member of the National Cancer Institute Thoracic Malignancies Steering Committee.

I direct a broad research program of therapeutic research with the ultimate goal of improving the outcome for patients with lung cancer. My research includes laboratory-based investigations to identify and test novel treatment approaches to lung cancer, early-phase clinical trials to bring these ideas to the clinic, and later-phase studies to establish the efficacy of these new approaches. We are interested in small cell and non-small cell lung cancers. Some of the strategies my group has explored both in the laboratory and in the clinic include turning back on genes silenced in cancer, re-activating cancer cell death pathways, and treating lung cancer with a cancer-specific virus

Appointments for New Patients
866-675-5864 (866-MSK-LUNG)
Clinical Expertise

Lung Cancer and Other Thoracic Malignancies; Developmental Therapies

Languages Spoken

MD, PhD, University of Chicago Pritzker School of Medicine


University of Chicago Medical Center


University of Chicago Medical Center

Board Certifications

Medical Oncology

Publications by Charles M. Rudin
Visit PubMed for full listing of Charles M. Rudin journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.
View Charles M. Rudin's laboratory research.